Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on: June 19,2024 8

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on:June 19,2024 8

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024 15

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024 15

Researchers discover a mechanism that controls the identity of stem cells

by University of California, IrvineCredit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.10.036Researchers at the University of California, Irvine, discovered a mechanism that contr

Updated on: February 03,2024 15

Researchers discover a mechanism that controls the identity of stem cells

by University of California, IrvineCredit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.10.036Researchers at the University of California, Irvine, discovered a mechanism that contr

Updated on:February 03,2024 15

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas

Updated on: January 23,2024 19

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas

Updated on:January 23,2024 19

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Updated on: January 23,2024 14

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Updated on:January 23,2024 14

Using a seaweed sugar to trigger immune responses that suppress melanomas

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Immunother

Updated on: February 03,2024 10

Using a seaweed sugar to trigger immune responses that suppress melanomas

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Immunother

Updated on:February 03,2024 10

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on: January 30,2024 17

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on:January 30,2024 17

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i

Updated on: January 13,2024 16

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i

Updated on:January 13,2024 16

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t

Updated on: April 01,2024 15

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t

Updated on:April 01,2024 15

Anti-sedative could alleviate cancer therapy side effects, study suggests

byRockefeller University PressCompared with a control (left), radiation treatment (center) destroys the structure of the mouse small intestine. But a healthy intestinal lining is maintained in t

Updated on: January 16,2024 13

Anti-sedative could alleviate cancer therapy side effects, study suggests

byRockefeller University PressCompared with a control (left), radiation treatment (center) destroys the structure of the mouse small intestine. But a healthy intestinal lining is maintained in t

Updated on:January 16,2024 13

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024 18

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024 18

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on: January 22,2024 12

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on:January 22,2024 12